Effect of Shatapushpa Tail Uttarbasti & Sharpunkha Ghan Vati in the treatment of Vandhyatva (Infertility due to Anovulation)
- Conditions
- Female infertility associated withanovulation. Ayurveda Condition: Female infertility,
- Registration Number
- CTRI/2023/07/055680
- Lead Sponsor
- Post Graduate Institute of Ayurved, Jodhpur, Rajasthan
- Brief Summary
In randomised comparative clinical trial on 30 diagnosed vandhyatva (female Infertility) w.s.r. Anovulatory factor. Female Patients of child Bearing age (18-40yrs) having active married life minimum 1 year
and suffering from Infertility with at least 2 or more consecutive anovulatory cycles were included. Female Patients having age less than 18years and more than 40years and Congenital deformities , infectious
diseases of reproductive tract like tuberculosis, Sexually transmitted diseases and carcinoma, DM, HIV, HTN were excluded. Group A patients were given with Sharpunkha Ghan Vati in a dose of 500 mg tds for 7 days for 2 month. Group B patients were given with Shatapushpa Tail Uttaarbasti 5 ml for 2 consecutive cycles.
Conclusion: In Nut cell, it can be concluded that Shatapushpa tail Uttarbasti is more effective compared to Sharpunkha Ghan Vati. Final conclusion of the study will be arrived at only after completion of the study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 30
- Patient having complaint of failure to conceive (due to Anovulation) within one or more year of regular unprotected coitus.
- Age groups-18 to 40 years 3.Primary or secondary infertility with Anovulatory factors.
- 1.Infertility due to other factor like uterine factor, cervical factor, tubal factor, peritoneal factor.
- 2.Infertility due to abnormality in male partner.
- 3.Patient suffering from chronic diseases like Hypertension, Diabetes mellitus, Malignancy, Thyroid disorder, Severe anaemia, Tuberculosis etc.
- 4.Patient suffering from Hepatitis B, sexually transmitted diseases, human immunodeficiency virus (HIV).
- 5.Congenital anatomical defect of female genital organ 6.Surgical factors like Ovarian tumour, Ovarian endometrioma, etc.
- 7.Contraindication of Uttar Basti (like Genital tract infection, heavy bleeding, etc.).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Dominant follicle size & Endometrial thickness. Improvement in Dominant follicle size & Endometrial thickness.
- Secondary Outcome Measures
Name Time Method Improvement in Interval of menstrual cycle, Duration of Bleeding, Dyspareunia 60 days
Trial Locations
- Locations (1)
Post Graduate Institute of Ayurved ,Jodhpur, Rajasthan
🇮🇳Jodhpur, RAJASTHAN, India
Post Graduate Institute of Ayurved ,Jodhpur, Rajasthan🇮🇳Jodhpur, RAJASTHAN, IndiaDr Kanchan ChoyalPrincipal investigator7734842989dr.kanchanchoudhary121@gmail.com